Diagnostics & biomarkers

Neurology Is Trying to Stop Nerves Dying, Not Just Treat What Is Left

BMI is not enough. Cardiometabolic risk is hiding in where fat lives

Resistant hypertension may need a diagnostic revolution, not just another drug

Japan Approves MRD Testing. Price Will Decide Whether Patients Can Use It.

Gonorrhoea Is Not Disappearing. Too Many Systems Are Failing to See It.
Type 1 diabetes has a kidney problem. FDA is now fast-tracking a possible answer.

The Biomarker Test Cannot Wait Until Relapse

When the Test Says Normal but the Pain Does Not

Gene therapy is entering cardiology. Friedreich ataxia shows why rare heart disease may be the first test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
